IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) announced that it has filed a New Drug Application (“NDA”) with the U.S.
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) investors cheer the news that the Canadian drug maker has entered into a license and commercial supply agreement with …
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) confirms that as of the date of this news release, they are not aware of any corporate developments …
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid …
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral …